No Detail Found!

Clinical effect of Low Molecular Weight Heparin Sodium Combined with Magnesium Sulfate in the Treatment of Patients with Severe Preeclampsia.

Author(s)
Jie Wen Department of Obstetrics and Gynecology, The Affiliated Hospital, North China University of Science and Technology, HeBei Province, 063000, China
Xiuqi Zhang Department of Obstetrics and Gynecology, Yulin First Hospital, Shaanxi Province, 718000, China
Chunji Li Department of Obstetrics and Gynecology, Yulin First Hospital, Shaanxi Province, 718000, China
Abstract
Objective: To investigate the effect of low molecular weight heparin sodium combined with magnesium sulfate in the treatment of patients with severe preeclampsia. Study Design: An experimental study. Place and Duration of Study: The Department of Obstetrics and Gynecology, The Affiliated Hospital, North China University of Science and Technology, from April 2016 to July 2017. Methodology: Patients with severe preeclampsia were randomly divided into observation group (52 cases) and control group (51 cases). In the control group, magnesium sulfate were used, but in observation group low molecular weight heparin sodium were added. After treatment of 7 days, serum TGF-b1, VCAM-1, ES levels and endothelial function markers of NO and ET-1 changes were compared between the two groups.The delivery status after treatment was observed in both groups. Results: After treatment of 7 days, serum TGF-b1 and NO levels in the observation group were higher than those in control group (both p<0.001), and VCAM-1, ES, ET-1, ET-1/NO levels in observation group were lower than those in control group (all p<0.001). Among the patients who delivered live births, observation group had a longer delivery gestation age after treatment than that of control group (p=0.038); placental quality, body mass and 1 minute Apgar score of surviving newborns in observation group were all higher than those in control group (all p<0.001). Conclusion: Low molecular weight heparin sodium combined with magnesium sulfate may improve the prognosis of neonates by reducing the infiltration ability of cytotrophoblasts and regulating endothelial cell function.
Publication Details
Page(s) 119-122
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 2, Year: 2019

Request the full text from PASTIC

References
BaghbahadoraniFK,MirajS., 2016.The impact of silymarin on improvement of platelet abnormalities in patients with severe preeclampsia,Electron Physician 8 2436 -42
PengM,YangM,YuL,DengY,LaiW, 2017.Mechanism of endogenous digitalis-like factor-induced vascular endothelial cell damage in patients with severe preeclampsia,Int J Mol Med 41 985 -94
LiX,LiC,DongX,GouW, 2014.-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase,Mol Med Rep 10 550 -4
CozziV,GarlandaC,NebuloniM,MainaV,MartinelliA,CalabreseS, 2012.PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR,Placenta 33 1039 -44
RoesEM,SteegersEA,ThomasCM,GeurtsmoespotA,RaijmakersMT,PetersWH, 2004.High levels of urinary vascular endothelial growth factor in women with severe preeclampsia,Int J Biol Markers 19 72 -5
FontenotMT,LewisDF,FrederickJB,WangY,DefrancoEA,GroomeLJ, 2005.A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy,Am J Obstet Gynecol 192 1788 -93
AaliBS,KhazaeliP,GhasemiF, 2008.Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy,J Obstet Gynaecol Res 34 138 -43
WangS,HuS,ZhongM., 2014.Proteomic investigation of the severe preeclampsia treatment by low molecular weight heparin,Clin Exp Obstet Gynecol 41 620 -6
SergioF,MariaCD,GabriellaF,GiorgiaS,CarolisSD,GiancarloP, 2006.Prophylaxis of recurrent preeclampsia: lowmolecular-weight heparin plus low-dose aspirin versus lowdose aspirin alone,Hypertens Pregnancy 25 115 -27
QuinnKH,LacoursiereDY,CuiL,BuiJ,ParastMM, 2011.The unique pathophysiology of early-onset severe preeclampsia: role of decidual t regulatory cells,J Reprod Immunol 91 76 -82
KuangD,HuaS., 2010.Perinatal characteristics and outcomes of the early onset severe preeclampsia,Tianjin Med J 38 262 -5
GraciaVD,Montufar-RuedaC,RuizJ, 2003.Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation,Eur J Obstet Gynecol Reprod Biol 107 24 -7
AnatoV,GarmendiaJV,BiancoNE, 2001.Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy,Ann Nutr Metab 45 190 -2
SinuaniI,AverbukhZ,GitelmanI,RapoportMJ,SandbankJ,AlbeckM, 2006.Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator as101 on this process,Am J Physiol Renal Physiol 291 384 -94
PulleynLJ,NewtonR,AdcockIM,BarnesPJ, 2001.TGF-fbeta1 allele association with asthma severity,Human Genetics 109 623 -7
MishraA,GuoY,LiZ,MoreS,WengT,ChintagariNR, 2016.A critical role for p2x7 receptor-induced vcam-1 shedding and neutrophil infiltration during acute lung injury,J Immunol 197 2828 -37
WangL,LiXH,NingWC, 2016.Evaluation of icam-1 and vcam-1 gene polymorphisms in patients with periodontal disease,Med Sci Monit 22 2386 -91
QiaoJ,YangJ,WangZ, 2017.Influence of rosuvastatin calcium on cardiac function and se-selectin,TGF-1 in patients with coronary heart disease complicated with paroxysmal atrial fibrillation,Int Med 12 474 -6
KimSY,RyuHM,YangJH,KimMY,AhnHK,LimHJ, 2004.Maternal serum levels of vcam-1, icam-1 and e-selectin in preeclampsia,J Korean Med Sci 19 688 -92
RoesEM,SteegersEA,ThomasCM,GeurtsmoespotA,RaijmakersMT,PetersWH, 2004.High levels of urinary vascular endothelial growth factor in women with severe preeclampsia,Int J Biol Markers 19 72 -5
TakahashiN,IshibashiY,ShimadaT,SakaneT,OhataS,SugamoriT, 2002.Impaired exercise-induced vasodilatation in chronic atrial fibrillation: role of endothelium-derived nitric oxide,Jap Circul J 66 583 -8
IglarzM,Clozel M.Mechanisms, 2007.-induced endothelial dysfunction,J Cardiovasc Pharmacol 50 621 -8
0

Citations

0

Downloads

83

Views